Dual effects of soluble CD14 on LPS priming of neutrophils

Journal of Leukocyte Biology

Volumn 61, Issue 2, 1997, Pages 173-178

  Troelstra, Annet ^a   Giepmans, Ben N G ^a   Van Kessel, Kok P M ^a   Lichenstein, Henri S ^b   Verhoef, Jan ^a   Van Strijp, Jos A G ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b AMGEN INC   (United States)

Author keywords

Chemiluminescence; Lipopolysaccharide; Lipopolysaccharide binding protein; N formyl methionyl leucyl phenylalanine

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOPOLYSACCHARIDE;

ARTICLE; CHEMOLUMINESCENCE; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; SERUM;

EID: 0031057869     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.61.2.173     Document Type: Article

References (41)

1. Bone, R. C. (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469.
2. Wright, S. D., Tobias, P. S., Ulevitch, R. J., Ramos, R. A. (1989) Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170, 1231-1241.
3. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., Mathison, J. C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.
4. Wright, S. D., Ramos, R. A., Hermanowski Vosatka, A., Rockwell, P., Detmers, P. A. (1991) Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173, 1281-1286.
5. Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., Goyert, S. M. (1988) The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141, 547-552.
6. Haziot, A., Tsuberi, B. Z., Goyert, S. M. (1993) Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J. Immunol. 150, 5556-5565.
7. Viriyakosol, S., Kirkland, T. N. (1995) A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270, 361-368.
8. Tobias, P. S., Soldau, K., Ulevitch, R. J. (1986) Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164, 777-793.
9. Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., Ulevitch, R. J. (1990) Structure and function of lipopolysaccharide binding protein. Science 249, 1429-1431.
10. Martin, T. R., Mathison, J. C., Tobias, P. S., Leturcq, D. J., Moriarty, A. M., Maunder, R. J., Ulevitch, R. J. (1992) Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs. J. Clin. Invest. 90, 2209-2219.
11. Mathison, J. C., Tobias, P. S., Wolfson, E., Ulevitch, R. J. (1992) Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J. Immunol. 149, 200-206.
12. Gallay, P., Heumann, D., Le Roy, D., Barras, C., Glauser, M. P. (1993) Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc. Natl. Acad. Sci. USA 90, 9935-9938.
13. Gallay, P., Carrel, S., Glauser, M. P., Barras, C., Ulevitch, R. J., Tobias, P. S., Baumgartner, J. D., Heumann, D. (1993) Purification and characterization of murine lipopolysaccharide-binding protein. Infect. Immun. 61, 378-383.
14. Tobias, R. S., Soldau, K., Ulevitch, R. J. (1989) Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264, 10867-10871.
15. Ulevitch, R. J. (1993) Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv. Immunol. 53, 267-289.
16. Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., Busse, L. A., Zukowski, M. M., Wright, S. D. (1994) Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179, 269-277.
17. Gallay, P., Jongeneel, C. V., Barras, C., Burnier, M., Baumgartner, J. D., Glauser, M. P., Heumann, D. (1993) Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J. Immunol. 150, 5086-5093.
18. Vosbeck, K., Tobias, P. S., Mueller, H., Allen, R. A., Arfors, K. E., Ulevitch, R. J., Sklar, L. A. (1990) Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J. Leukoc. Biol. 47, 97-104.
19. Weingarten, R., Sklar, L. A., Mathison, J. C, Omidi, S., Ainsworth, T., Simon, S., Ulevitch, R. J., Tobias, P. S. (1993) Interactions of lipopolysaccharide with neutrophils in blood via CD14. J. Leukoc. Biol. 53, 518-524.
20. Worthen, G. S., Avdi, N., Vukajlovich, S., Tobias, P. S. (1992) Neutrophil adherence induced by lipopolysaccharide in vitro. Role of plasma component interaction with lipopolysaccharide. J. Clin. Invest. 90, 2526-2535.
21. Yasui, K., Komiyama, A., Molski, T. F. P., Sha'afi, R. (1994) Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of Superoxide by lipopolysaccharide: possible mechanism of these actions. Infect. Immun. 62, 922-927.
22. Aida, Y. M., Pabst, J. (1990) Priming of neutrophils by lipopolysaccharide for enhanced release of Superoxide. J. Immunol. 145, 3017-3025.
23. Bazil, V., Horesji, V., Baudys, M., Kristofova, H., Strominger, J. L., Kostka, W., Hilgert, I. (1986) Biochemical characterisation of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16, 1583-1589.
24. Bazil, V., Strominger, J. L. (1991) Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147, 1567-1574.
25. Grunwald, U., Kruger, C., Westermann, J., Lukowsky, A., Ehlers, M., Schutt, C. (1992) An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. J. Immunol. Meth. 155, 225-232.
26. Landman, R., Zimmerli, W., Sansano, S., Link, S., Hahn, A., Glauser, M. P., Calandra, T. (1995) Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 171, 639-644.
27. Maliszewski, C. R. (1991) CD14 and immune response to lipopolysaccharide. Science 252, 1321.
28. Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B., Wright, S. D. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176, 1665-1671.
29. Haziot, A., Rong, G. W., Silver, J., Goyert, S. M. (1993) Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151, 1500-1507.
30. Pugin, J., Schurer Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., Tobias, P. S. (1993) Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90, 2744-2748.
31. Arditi, M., Zhou, J., Dorio, R., Rong, G. W., Goyert, S. M., Kim, K. S. (1993) Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61, 3149-3156.
32. Read, M. A., Cordle, S. R., Veach, R. A., Carlisle, C. D., Hawiger, J. (1993) Cell free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA 90, 9887-9891.
33. Juan, T. S., Kelley, M. J., Johnson, D. A., Busse, L. A., Hailman, E., Wright, S. D., Lichenstein, H. S. (1995) Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270, 1382-1387.
34. Juan, T. S., Hailman, E., Kelley, M. J., Busse, L. A., Davy, E., Empig, C. J., Narhi, L. O., Wright, S. D., Lichenstein, H. S. (1995) Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270, 5219-5224.
35. Haziot, A., Rong, G. W., Bazil, V., Silver, J., Goyert, S. M. (1994) Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor a production by cells in whole blood. J. Immunol. 152, 5868-5876.
36. Schutt, C., Schilling, T, Grunwald, U., Schonfeld, W., Kruger, C. (1992) Endotoxin-neutralizing capacity of soluble CD14. Res. Immunol. 143, 71-78.
37. Haziot, A., Rong, G. W, Lin, X. Y., Silver, J., Goyert, S. M. (1995) Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154, 6529-6532.
38. Van Deventer, J. H., Buller, H. R., Ten Cate, J. W., Sturk, A., Pauw, W. (1988) Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet i, 8586, 605-608.
39. Hailman, E., Vasselon, T., Kelley, M., Busse, L. A., Hu, M. C.-T., Lichenstein, H. S., Detmers, P. A., Wright, S. D. (1996) Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156, 4384-4390.
40. Gallay, P., Heumann, D., Le Roy, D., Barras, C., Glauser, M. P. (1994) Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice. Proc. Natl. Acad. Sci. USA 91, 7922-7926.
41. Goldblum, S. E., Brann, T. W., Ding, X., Pugin, J., Tobias, P. S. (1994) Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J. Clin. Invest. 93, 692-702.